Caden Capital Partners’s Amgen AMGN Stock Holding History

Caden Capital Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$258K	Hold	712	–	–	3.11%	7
2026 Q1	$251K	Buy	712 +416	+141%	+$148K	3.09%	8
2025 Q4	$96.9K	Buy	+296	New	+$93.9K	0.22%	31

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Caden Capital Partners's AMGN Position: Q2 2026 in Review

Caden Capital Partners held its Amgen (AMGN) position steady in Q2 2026 at 712 shares worth $258K. The position accounts for 3.11% of the portfolio, ranked #7.

Caden Capital Partners first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Caden Capital Partners held 712 shares of Amgen worth $258K as of Q2 2026.
Caden Capital Partners left its Amgen share count unchanged in Q2 2026.
Amgen made up 3.11% of Caden Capital Partners's portfolio in Q2 2026, its #7 holding.
Caden Capital Partners first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Caden Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.